Differential regulation and function of the Fas/Fas ligand system in human trophoblast cells

Biology of Reproduction

Volumn 66, Issue 6, 2002, Pages 1853-1861

  Aschkenazi, Sarit ^a   Straszewski, Shawn ^a   Verwer, Karlijn M A ^a   Foellmer, Harald ^a   Rutherford, Thomas ^a   Mor, Gil ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; Cytokines; Fas FasL; Placenta; Pregnancy

Indexed keywords

CYTOKINE; FAS LIGAND; FLICE INHIBITORY PROTEIN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 6; CARRIER PROTEIN; CFLAR PROTEIN, HUMAN; FAS ANTIGEN; FASLG PROTEIN, HUMAN; MEMBRANE PROTEIN; SIGNAL PEPTIDE; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNITY; PREGNANCY; PRIORITY JOURNAL; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TH1 CELL; TH2 CELL; TROPHOBLAST; WESTERN BLOTTING; CELL CULTURE; FEMALE; GENE EXPRESSION REGULATION; GENETICS; GESTATIONAL AGE; METABOLISM; PHYSIOLOGY;

MAMMALIA;

ANTIGENS, CD95; APOPTOSIS; BLOTTING, WESTERN; CARRIER PROTEINS; CASP8 AND FADD-LIKE APOPTOSIS REGULATING PROTEIN; CELLS, CULTURED; CYTOKINES; FAS LIGAND PROTEIN; FEMALE; GENE EXPRESSION REGULATION; GESTATIONAL AGE; HUMANS; INTERFERON TYPE II; INTERLEUKIN-10; INTERLEUKIN-6; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MEMBRANE GLYCOPROTEINS; PREGNANCY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TH1 CELLS; TH2 CELLS; TROPHOBLASTS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0035988264     PISSN: 00063363     EISSN: None     Source Type: Journal    
DOI: 10.1095/biolreprod66.6.1853     Document Type: Article

References (72)

1. Implantation and the survival of early pregnancy
2. Immune signaling at the maternal-fetal interface and trophoblast differentiation
3. Immunology at the maternal-fetal interface: Lessons for T cell tolerance and suppression
4. Human trophoblast invasion. Autocrine control and paracrine modulation
5. Localization of proinflammatory (IL-12, IL-15) and anti-inflammatory (IL-11, IL-13) cytokines at the fetomaternal interface during murine pregnancy
6. Uterine leukocytes: Key players in pregnancy
7. Th1-and Th2-type lymphokine-assisted induction and release of chemokine receptors from primary human trophoblast cells
8. Cytokines and embryo implantation
9. Bidirectional cytokine interactions in the maternal-fetal relationship: Is successful pregnancy a TH2 phenomenon?
10. IL-10 is an autocrine inhibitor of human placental cytotrophoblast MMP-9 production and invasion
11. Modulations of cytokine expression in pregnant women
12. Cytokine expression by first-trimester human chorionic villi
13. Cytokine expression by models of human trophoblast as assessed by a semiquantitative reverse transcription-polymerase chain reaction technique
14. Cytokines and the regulation of apoptosis in reproductive tissues: A review
15. Gestational age-dependent expression of IL-10 and its receptor in human placental tissues and isolated cytotrophoblasts
16. Cytokine production and cytokine receptor expression by cells of the human first-trimester placental-uterine interface
17. Cachectin/tumor necrosis factor-α formation in human decidua. Potential role of cytokines in infection-induced preterm labor
18. Cytokines and infection-induced preterm labor
19. Cytokine networks in the uteroplacental unit: Macrophages as pivotal regulatory cells
20. Cytotoxicity of tumor necrosis factor-α and γ-interferon against primary human placental trophoblasts
21. Fas and Fas ligand: A death factor and its receptor
22. Expression of Fas and Fas ligand during pregnancy, lactation and involution and its potential role during mammary gland remodeling
23. The Fas death factor
24. Resistance of cultured peripheral T cells towards activation induced cell death involves a lack of recruitment of FLICE (MACH/Caspase 8) to the CD95 death-inducing signaling complex
25. Die and let live: Eliminating dangerous lymphocytes
26. The cDNA structure, expression and chromosomal assignment of the mouse Fas antigen
27. The role of FasL-induced apoptosis in immune privilege
28. FasL (CD95L, Apo1L) is expressed in the normal rat and human brain-evidence for the existence of an immunological brain barrier
29. The Fas/Fas-Ligand system: A mechanism for immune evasion in human breast carcinomas
30. Fas-Fas ligand system induced apoptosis in human placenta and gestational trophoblastic disease
31. Fas-Fas ligand system induced apoptosis in human placenta and gestational trophoblastic disease
32. Placental Fas ligand expression is a mechanism for maternal immune tolerance to the fetus
33. Trophoblasts express Fas ligand: A proposed mechanism for immune privilege in placenta and maternal invasion
34. Expression of Fas ligand by human cytotrophoblast: Implications in placentation and fetal survival
35. Death receptor Fas/Apo-1/CD95 expressed by human placental cytotrophoblasts does not mediate apoptosis
36. Apoptosis and Fas expression in human fetal membranes
37. Fas ligand is not only expressed in immune privileged human organs but is also coexpressed with Fas in various epithelial tissues
38. Regulation of Fas ligand expression by estrogen in normal ovary
39. Fas ligand expression is restricted to nonlymphoid thymic components in situ
40. Regulation of the proinflammatory effects of Fas ligand (CD95L)
41. Macrophage-derived growth factors regulate FasL expression in endometrial stromal cells
42. The regulation of FasL expression - A distinguishing feature between monocytes and T lymphocytes/NK cells with possible implications for SLE
43. Caspase 1-independent IL-1β release and inflammation induced by the apoptosis inducer Fas ligand
44. Regulation of Fas ligand expression in breast cancer cells by estrogen: Functional differences between estradiol and tamoxifen
45. 1 and IL-12 to regulate human FasL and mTNF alloreactive cytotoxic T-cell pathways
46. Laminin in human trophoblast-decidua interaction
47. Macrophage-derived growth factors modulate Fas ligand expression in cultured trophoblast cells: A role in implantation
48. Hyperglycosylated human chorionic gonadotropin (invasive trophoblast antigen) immunoassay: A new basis for gestational Down syndrome screening
49. Lethal effect of the anti-Fas antibody in mice
50. Cytokine network at the fetomaternal interface
51. A brief review of recent data on some cytokine expressions at the maternofetal interface which might challenge the classical Th1/Th2 dichotomy
52. Membrane Fas ligand kills human peripheral blood T lymphocytes, and soluble Fas ligand blocks the killing
53. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family
54. A vision of cell death-insights into immune privilege
55. Expression of the apoptosis-inducing Fas ligand (FasL) in human first- and third-trimester placenta and choriocarcinoma cells
56. Inhibition of death receptor signals by cellular FLIP
57. The role of c-FLIP in modulation of CD95-induced apoptosis
58. Activation of the CD95 (APO-1/Fas) pathway in drug- and gamma-irradiation-induced apoptosis of brain tumor cells
59. Influence of estrogen and progesterone on macrophage distribution in the mouse uterus
60. Progesterone via its receptor antagonizes the proinflammatory activity of estrogen in the mouse uterus
61. Sex steroids hormones and macrophage function
62. Macrophages and implantation
63. Corpse clearance defines the meaning of cell death
64. Immunosuppressive effects of apoptotic cells
65. Apoptotic cell clearance in systemic lupus erythematosus. I. Opsonization by anti-phospholipid antibodies
66. The trophoblast is a component of the innate immune system during pregnancy
67. Apoptosis in cancer therapy
68. Placental apoptosis in preeclampsia
69. The neutrophil and preeclampsia
70. Neutrophil activation is confined to the maternal circulation in pregnancy-induced hypertension
71. Neutrophil activation in pregnancy-induced hypertension
72. Human umbilical vein endothelial cell killing by activated neutrophils. Loss of sensitivity to injury is accompanied by decreased iron content during in vitro culture and is restored with exogenous iron